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Introduction: Prognostic models exist for the purpose of stratifying patients with acute 
pulmonary embolism. Of these, the Pulmonary Embolism Severity Index (PESI) and the 
simplified PESI (sPESI) are the most well-known, although more recent composite models, like 
the BOVA score, are now being studied and implemented. Comparative efficacy of these scores 
to predict long term mortality is not well established.  
Methods: We performed a retrospective analysis of all consecutive patients diagnosed with PE 
using computed tomography scan from 2014-2016 at an urban tertiary-referral medical center. 
Cox proportional hazard analyses were performed to compare the performance of two 
prognostic models – sPESI and BOVA – to predict all-cause in-hospital and cumulative one-year 
mortality.  
Results: The all-cause in-hospital mortality rate was 6.0%, and cumulative one-year mortality 
rate was 21.3%. 
In adjusted analyses, a BOVA score >4 was significantly associated with an increased in-hospital 
mortality (HR 3.5, 95% CI: 1.4-9.0, p = 0.009) and one-year mortality (HR 2.0, 95% CI: 1.0-3.9, p 
= 0.04), as compared to a BOVA score <4. However, the sPESI (p = 0.14) did not show a 
significant association with one-year mortality.  
In identifying in-hospital mortality, the sPESI had high sensitivity (100%) and low specificity 
(10.1%), whereas the BOVA score had low sensitivity (20.0%) and high specificity (92.7%). 
Similar trends were seen for one-year mortality.  
Conclusion: In this study, a high BOVA score was found to be the best predictor of both short 
and long-term mortality in PE patients. A low sPESI score identified with high sensitivity patients 
with low-risk PEs.  
